{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T07:40:06Z","timestamp":1788248406012,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01EB033764"],"award-info":[{"award-number":["R01EB033764"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01EB033764"],"award-info":[{"award-number":["R01EB033764"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Imaging"],"DOI":"10.1038\/s44303-025-00113-y","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T05:35:10Z","timestamp":1761284110000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Oral intake of deuterated choline at clinical dose for metabolic imaging of brain tumors"],"prefix":"10.1038","volume":"3","author":[{"given":"Victor E.","family":"Osoliniec","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique A.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin A.","family":"de Graaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk M.","family":"De Feyter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"key":"113_CR1","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1055\/s-0037-1608657","volume":"37","author":"J Dietrich","year":"2017","unstructured":"Dietrich, J., Winter, S. F. & Klein, J. P. Neuroimaging of brain tumors: pseudoprogression, pseudoresponse, and delayed effects of chemotherapy and radiation. Semin. Neurol. 37, 589\u2013596 (2017).","journal-title":"Semin. Neurol."},{"key":"113_CR2","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1148\/radiology.217.2.r00nv36377","volume":"217","author":"AJ Kumar","year":"2000","unstructured":"Kumar, A. J. et al. Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment. Radiology 217, 377\u2013384 (2000).","journal-title":"Radiology"},{"key":"113_CR3","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s11060-017-2375-2","volume":"134","author":"BM Ellingson","year":"2017","unstructured":"Ellingson, B. M., Chung, C., Pope, W. B., Boxerman, J. L. & Kaufmann, T. J. Pseudoprogression, radionecrosis, inflammation or true tumor progression? challenges associated with glioblastoma response assessment in an evolving therapeutic landscape. J. Neurooncol. 134, 495\u2013504 (2017).","journal-title":"J. Neurooncol."},{"key":"113_CR4","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1093\/neuonc\/noz048","volume":"21","author":"SF Winter","year":"2019","unstructured":"Winter, S. F. et al. Treatment-induced brain tissue necrosis: a clinical challenge in neuro-oncology. Neuro Oncol. 21, 1118\u20131130 (2019).","journal-title":"Neuro Oncol."},{"key":"113_CR5","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nrneurol.2017.44","volume":"13","author":"K-J Langen","year":"2017","unstructured":"Langen, K.-J., Galldiks, N., Hattingen, E. & Shah, N. J. Advances in neuro-oncology imaging. Nat. Rev. Neurol. 13, 279\u2013289 (2017).","journal-title":"Nat. Rev. Neurol."},{"key":"113_CR6","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nrclinonc.2016.108","volume":"13","author":"MM Kim","year":"2016","unstructured":"Kim, M. M., Parolia, A., Dunphy, M. P. & Venneti, S. Non-invasive metabolic imaging of brain tumours in the era of precision medicine. Nat. Rev. Clin. Oncol. 13, 725\u2013739 (2016).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"113_CR7","doi-asserted-by":"publisher","first-page":"eaat7314","DOI":"10.1126\/sciadv.aat7314","volume":"4","author":"HM De Feyter","year":"2018","unstructured":"De Feyter, H. M. et al. Deuterium metabolic imaging (DMI) for MRI-based 3D mapping of metabolism in vivo. Sci. Adv. 4, eaat7314 (2018).","journal-title":"Sci. Adv."},{"key":"113_CR8","doi-asserted-by":"publisher","first-page":"106932","DOI":"10.1016\/j.jmr.2021.106932","volume":"326","author":"HM De Feyter","year":"2021","unstructured":"De Feyter, H. M. & de Graaf, R. A. Deuterium metabolic imaging\u2014back to the future. J. Magn. Reson. 326, 106932 (2021).","journal-title":"J. Magn. Reson."},{"key":"113_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s42255-024-01203-8","volume":"7","author":"TC Kenny","year":"2025","unstructured":"Kenny, T. C., Scharenberg, S., Abu-Remaileh, M. & Birsoy, K. Cellular and organismal function of choline metabolism. Nat. Metab. 7, 35\u201352 (2025).","journal-title":"Nat. Metab."},{"key":"113_CR10","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/j.1349-7006.1999.tb00764.x","volume":"90","author":"K Nakagami","year":"1999","unstructured":"Nakagami, K. et al. Increased choline kinase activity and elevated phosphocholine levels in human colon cancer. Jpn J. Cancer Res. 90, 419\u2013424 (1999).","journal-title":"Jpn J. Cancer Res."},{"key":"113_CR11","doi-asserted-by":"crossref","unstructured":"Ram\u00edrez de Molina, A. et al. Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers. Biochem. Biophys. Res. Commun. 296, 580\u2013583 (2002).","DOI":"10.1016\/S0006-291X(02)00920-8"},{"key":"113_CR12","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1158\/0008-5472.CAN-09-3833","volume":"70","author":"E Iorio","year":"2010","unstructured":"Iorio, E. et al. Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells. Cancer Res. 70, 2126\u20132135 (2010).","journal-title":"Cancer Res."},{"key":"113_CR13","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/nbm.1361","volume":"22","author":"C Gabellieri","year":"2009","unstructured":"Gabellieri, C. et al. Modulation of choline kinase activity in human cancer cells observed by dynamic 31P NMR. NMR Biomed. 22, 456\u2013461 (2009).","journal-title":"NMR Biomed."},{"key":"113_CR14","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1038\/onc.2009.91","volume":"28","author":"E Hernando","year":"2009","unstructured":"Hernando, E. et al. A critical role for choline kinase-alpha in the aggressiveness of bladder carcinomas. Oncogene 28, 2425\u20132435 (2009).","journal-title":"Oncogene"},{"key":"113_CR15","doi-asserted-by":"crossref","unstructured":"Ip, K. L., Thomas, M. A., Behar, K. L., de Graaf, R. A. & De Feyter, H. M. Mapping of exogenous choline uptake and metabolism in rat glioblastoma using deuterium metabolic imaging (DMI). Front. Cell. Neurosci. 17 (2023).","DOI":"10.3389\/fncel.2023.1130816"},{"key":"113_CR16","first-page":"1375","volume":"16","author":"R Katz-Brull","year":"1996","unstructured":"Katz-Brull, R. & Degani, H. Kinetics of choline transport and phosphorylation in human breast cancer cells; NMR application of the zero trans method. Anticancer Res. 16, 1375\u20131380 (1996).","journal-title":"Anticancer Res."},{"key":"113_CR17","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.1158\/0008-5472.CAN-03-3829","volume":"64","author":"K Glunde","year":"2004","unstructured":"Glunde, K., Jie, C. & Bhujwalla, Z. M. Molecular causes of the aberrant choline phospholipid metabolism in breast cancer. Cancer Res. 64, 4270\u20134276 (2004).","journal-title":"Cancer Res."},{"key":"113_CR18","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.bbalip.2012.09.009","volume":"1831","author":"P Fagone","year":"2013","unstructured":"Fagone, P. & Jackowski, S. Phosphatidylcholine and the CDP-choline cycle. Biochim. Biophys. Acta 1831, 523\u2013532 (2013).","journal-title":"Biochim. Biophys. Acta"},{"key":"113_CR19","unstructured":"Hudson EL, Jones EB. Cholinergic Toxicity(Archived) [Updated 2022 Dec 5]. In: StatPearls [Internet]. Treasure Island (FL): StatPearlsPublishing; 2025 Jan-. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK539783\/"},{"key":"113_CR20","unstructured":"Office of Dietary Supplements\u2014Choline. https:\/\/ods.od.nih.gov\/factsheets\/Choline-HealthProfessional\/."},{"key":"113_CR21","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/j.1471-4159.1991.tb03762.x","volume":"57","author":"J Klein","year":"1991","unstructured":"Klein, J., K\u00f6ppen, A. & L\u00f6ffelholz, K. Uptake and storage of choline by rat brain: influence of dietary choline supplementation. J. Neurochem 57, 370\u2013375 (1991).","journal-title":"J. Neurochem"},{"key":"113_CR22","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/clpt.1994.28","volume":"55","author":"AL Buchman","year":"1994","unstructured":"Buchman, A. L. et al. Choline pharmacokinetics during intermittent intravenous choline infusion in human subjects. Clin. Pharmacol. Therapeut. 55, 277\u2013283 (1994).","journal-title":"Clin. Pharmacol. Therapeut."},{"key":"113_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF01868535","volume":"119","author":"A Garcia-Perez","year":"1991","unstructured":"Garcia-Perez, A. & Burg, M. B. Role of organic osmolytes in adaptation of renal cells to high osmolality. J. Membr Biol. 119, 1\u201313 (1991).","journal-title":"J. Membr Biol."},{"key":"113_CR24","doi-asserted-by":"publisher","unstructured":"de Graaf, R. A., Thomas, M. A. & De Feyter, H. M. Metabolism of choline and deuterated choline detected by 1H\u201314N 2D heteronuclear single-quantum coherence (HSQC) NMR. Anal. Chem. https:\/\/doi.org\/10.1021\/acs.analchem.4c06235 (2025).","DOI":"10.1021\/acs.analchem.4c06235"},{"key":"113_CR25","doi-asserted-by":"publisher","first-page":"74S","DOI":"10.2967\/jnumed.120.251942","volume":"61","author":"SM Larson","year":"2020","unstructured":"Larson, S. M. Gallagher\u2019s principle of metabolic trapping (perspective on \u201cMetabolic trapping as a principle of radiopharmaceutical design: some factors responsible for biodistribution of [18F]2-deoxy-2-fluoro-D-glucose\u201d. J Nucl Med. 1978;19:1154\u20131161). J. Nucl. Med. 61, 74S\u201382S (2020).","journal-title":"J. Nucl. Med."},{"key":"113_CR26","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/BF02662511","volume":"6","author":"R Katz-Brull","year":"1998","unstructured":"Katz-Brull, R., Margalit, R., Bendel, P. & Degani, H. Choline metabolism in breast cancer; 2H-, 13C- and 31P-NMR studies of cells and tumors. MAGMA 6, 44\u201352 (1998).","journal-title":"MAGMA"},{"key":"113_CR27","doi-asserted-by":"publisher","first-page":"10348","DOI":"10.1073\/pnas.1903282116","volume":"116","author":"Y Hai","year":"2019","unstructured":"Hai, Y., Huang, A. M. & Tang, Y. Structure-guided function discovery of an NRPS-like glycine betaine reductase for choline biosynthesis in fungi. Proc. Natl. Acad. Sci. USA 116, 10348\u201310353 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"113_CR28","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1093\/neuonc\/nox175","volume":"20","author":"JN Sarkaria","year":"2018","unstructured":"Sarkaria, J. N. et al. Is the blood\u2013brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data. Neuro Oncol. 20, 184\u2013191 (2018).","journal-title":"Neuro Oncol."},{"key":"113_CR29","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s11060-009-9875-7","volume":"94","author":"RF Barth","year":"2009","unstructured":"Barth, R. F. & Kaur, B. Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas. J. Neurooncol. 94, 299\u2013312 (2009).","journal-title":"J. Neurooncol"},{"key":"113_CR30","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1093\/neuonc\/now088","volume":"18","author":"HM De Feyter","year":"2016","unstructured":"De Feyter, H. M. et al. A ketogenic diet increases transport and oxidation of ketone bodies in RG2 and 9L gliomas without affecting tumor growth. Neuro-Oncol. 18, 1079\u20131087 (2016).","journal-title":"Neuro-Oncol."},{"key":"113_CR31","doi-asserted-by":"publisher","first-page":"4034","DOI":"10.3390\/cancers13164034","volume":"13","author":"A Veltien","year":"2021","unstructured":"Veltien, A. et al. Simultaneous recording of the uptake and conversion of glucose and choline in tumors by deuterium metabolic imaging. Cancers 13, 4034 (2021).","journal-title":"Cancers"},{"key":"113_CR32","doi-asserted-by":"publisher","first-page":"118639","DOI":"10.1016\/j.neuroimage.2021.118639","volume":"244","author":"L Ruhm","year":"2021","unstructured":"Ruhm, L. et al. Deuterium metabolic imaging in the human brain at 9.4 Tesla with high spatial and temporal resolution. NeuroImage 244, 118639 (2021).","journal-title":"NeuroImage"},{"key":"113_CR33","doi-asserted-by":"publisher","first-page":"119284","DOI":"10.1016\/j.neuroimage.2022.119284","volume":"257","author":"JD Kaggie","year":"2022","unstructured":"Kaggie, J. D. et al. Deuterium metabolic imaging and hyperpolarized 13C-MRI of the normal human brain at clinical field strength reveals differential cerebral metabolism. NeuroImage 257, 119284 (2022).","journal-title":"NeuroImage"},{"key":"113_CR34","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/mrm.29830","volume":"91","author":"PM Adamson","year":"2024","unstructured":"Adamson, P. M. et al. Deuterium metabolic imaging for 3D mapping of glucose metabolism in humans with central nervous system lesions at 3T. Magn. Reson. Med. 91, 39\u201350 (2024).","journal-title":"Magn. Reson. Med."},{"key":"113_CR35","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1002\/jmri.29532","volume":"61","author":"N Ahmadian","year":"2025","unstructured":"Ahmadian, N. et al. Human brain deuterium metabolic imaging at 7 T: impact of different [6,6\u2032-H]glucose doses. J. Magn.Reson. Imaging 61, 1170\u20131178 (2025).","journal-title":"J. Magn.Reson. Imaging"},{"key":"113_CR36","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1002\/mrm.29379","volume":"88","author":"F Hesse","year":"2022","unstructured":"Hesse, F. et al. Deuterium MRSI of tumor cell death in vivo following oral delivery of 2H-labeled fumarate. Magn. Reson. Med. 88, 2014\u20132020 (2022).","journal-title":"Magn. Reson. Med."},{"key":"113_CR37","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/mrm.29196","volume":"88","author":"Y Liu","year":"2022","unstructured":"Liu, Y. et al. Interleaved fluid-attenuated inversion recovery (FLAIR) MRI and deuterium metabolic imaging (DMI) on human brain in vivo. Magn. Reson. Med. 88, 28\u201337 (2022).","journal-title":"Magn. Reson. Med."},{"key":"113_CR38","doi-asserted-by":"publisher","first-page":"e241597","DOI":"10.1148\/radiol.241597","volume":"315","author":"Y Liu","year":"2025","unstructured":"Liu, Y. et al. Parallel detection of multicontrast MRI and deuterium metabolic imaging for time-efficient characterization of neurologic diseases. Radiology 315, e241597 (2025).","journal-title":"Radiology"},{"key":"113_CR39","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1093\/neuonc\/noac022","volume":"24","author":"C Taglang","year":"2022","unstructured":"Taglang, C. et al. Deuterium magnetic resonance spectroscopy enables noninvasive metabolic imaging of tumor burden and response to therapy in low-grade gliomas. Neuro-Oncol. 24, 1101\u20131112 (2022).","journal-title":"Neuro-Oncol."},{"key":"113_CR40","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1177\/0271678X221074211","volume":"42","author":"LM McNair","year":"2022","unstructured":"McNair, L. M. et al. Rates of pyruvate carboxylase, glutamate and GABA neurotransmitter cycling, and glucose oxidation inmultiple brain regions of the awake rat using a combination of [2-13C]\/[1-13C]glucose infusion and 1H-[13C]NMR ex vivo. J.Cereb. Blood Flow. Metab 42, 1507\u20131523 (2022).","journal-title":"J.Cereb. Blood Flow. Metab"},{"key":"113_CR41","first-page":"712","volume":"22","author":"R Hagemann","year":"1970","unstructured":"Hagemann, R., Nief, G. & Roth, E. Absolute isotopic scale for deuterium analysis of natural waters. Absolute D\/H ratio for SMOW. Tellus 22, 712\u2013715 (1970).","journal-title":"Tellus"},{"key":"113_CR42","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/nbm.1940030405","volume":"3","author":"J Eng","year":"1990","unstructured":"Eng, J., Berkowitzt, B. A. & Balaban, R. S. Renal distribution and metabolism of [2H9]choline. A 2H NMR and MRI study. NMR Biomed. 3, 173\u2013177 (1990).","journal-title":"NMR Biomed."},{"key":"113_CR43","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.neuroimage.2006.01.015","volume":"31","author":"PA Yushkevich","year":"2006","unstructured":"Yushkevich, P. A. et al. User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. NeuroImage 31, 1116\u20131128 (2006).","journal-title":"NeuroImage"},{"key":"113_CR44","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1006\/jmre.1998.1425","volume":"132","author":"L Vanhamme","year":"1998","unstructured":"Vanhamme, L., Fierro, R. D., Van Huffel, S. & de Beer, R. Fast removal of residual water in proton spectra. J. Magn. Reson. 132, 197\u2013203 (1998).","journal-title":"J. Magn. Reson."}],"container-title":["npj Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44303-025-00113-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44303-025-00113-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44303-025-00113-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T05:35:12Z","timestamp":1761284112000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44303-025-00113-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["113"],"URL":"https:\/\/doi.org\/10.1038\/s44303-025-00113-y","relation":{},"ISSN":["2948-197X"],"issn-type":[{"value":"2948-197X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"29 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"54"}}